Artiva Biotherapeutics, Inc.
ARTV
56 insider filings · Latest: Oct 6, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 19, 2026 | May 20 1:50 AM | Fred AslanDirector, Chief Executive Officer | Sale | 27,116 | $9.01 | $244.3K | 1,535,082(D) | View → |
| May 18, 2026 | May 18 11:54 PM | Heather Raymon | Proposed Sale | 3,500 | $9.22 | $32.3K | — | View → |
| May 18, 2026 | May 18 11:53 PM | Christopher P. Horan | Proposed Sale | 7,500 | $9.22 | $69.2K | — | View → |
| May 18, 2026 | May 18 11:51 PM | Jennifer Bush | Proposed Sale | 9,000 | $9.22 | $83.0K | — | View → |
| May 18, 2026 | May 18 11:49 PM | Subhashis Banerjee | Proposed Sale | 7,000 | $9.22 | $64.5K | — | View → |
| May 18, 2026 | May 18 11:48 PM | Fred Aslan, M.D. | Proposed Sale | 28,000 | $9.22 | $258.2K | — | View → |
| May 11, 2026 | May 13 9:45 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Purchase | 6,510,416 | $11.52 | $75.0M | 15,203,995(I) | View → |
| Dec 15, 2025 | Dec 15 9:18 PM | FRED ASLAN | Proposed Sale | 12,749 | $3.30 | $42.1K | — | View → |
| Nov 17, 2025 | Nov 17 9:29 PM | FRED ASLAN | Proposed Sale | 6,375 | $3.25 | $20.7K | — | View → |
| Oct 17, 2025 | Oct 17 8:17 PM | FRED ASLAN | Proposed Sale | 25,500 | $2.77 | $70.6K | — | View → |
| Aug 15, 2025 | Aug 15 8:24 PM | FRED ASLAN | Proposed Sale | 25,500 | $2.70 | $68.8K | — | View → |
← Previous
Page 3 of 3
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | Sep 15 8:44 PM | Fred AslanDirector, Chief Executive Officer | Grant/Award | 315,000 | $8.91 | 315,000(D) | View → |
| Sep 10, 2026 | Sep 15 12:07 AM | Fred AslanDirector, Chief Executive Officer | Grant/Award | 155,000 | $10.42 | 155,000(D) | View → |
| Sep 10, 2026 | Sep 14 10:46 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Grant/Award | 16,250 | $10.42 | 16,250(I) | View → |
| Sep 10, 2026 | Sep 14 8:05 PM | Laura StoppelDirector | Grant/Award | 16,250 | $10.42 | 16,250(D) | View → |
| Sep 10, 2026 | Sep 14 8:04 PM | Elaine K. SorgDirector | Grant/Award | 16,250 | $10.42 | 16,250(D) | View → |
| Sep 10, 2026 | Sep 14 8:04 PM | HOUGEN ELIZABETH LDirector | Grant/Award | 16,250 | $10.42 | 16,250(D) | View → |
| Sep 10, 2026 | Sep 14 8:03 PM | Brian DanielsDirector | Grant/Award | 16,250 | $10.42 | 16,250(D) | View → |
| Sep 10, 2026 | Sep 14 8:03 PM | Daniel G. BakerDirector | Grant/Award | 16,250 | $10.42 | 16,250(D) | View → |
| Sep 10, 2026 | Sep 14 8:02 PM | Alison MooreDirector | Grant/Award | 16,250 | $10.42 | 16,250(D) | View → |
| Sep 9, 2026 | Sep 11 10:37 PM | Gines Diego MirallesPresident & Head of R&D | Grant/Award | 135,000 | $10.79 | 135,000(D) | View → |
| Sep 9, 2026 | Sep 11 10:36 PM | Christopher HoranChief Tech Operations Officer | Grant/Award | 120,000 | $10.79 | 120,000(D) | View → |
| Sep 9, 2026 | Sep 11 10:36 PM | Jennifer BushCOO, CLO, Compliance Officer | Grant/Award | 135,000 | $10.79 | 135,000(D) | View → |
| Sep 9, 2026 | Sep 11 10:35 PM | Subhashis BanerjeeChief Medical Officer | Grant/Award | 85,000 | $10.79 | 85,000(D) | View → |
| Sep 8, 2026 | Sep 8 10:29 PM | RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner | Grant/Award | 13,750 | $10.88 | 13,750(I) | View → |
| Sep 8, 2026 | Sep 8 9:58 PM | Laura StoppelDirector | Grant/Award | 13,750 | $10.88 | 13,750(D) | View → |
| Sep 8, 2026 | Sep 8 9:57 PM | Elaine K. SorgDirector | Grant/Award | 13,750 | $10.88 | 13,750(D) | View → |
| Sep 8, 2026 | Sep 8 9:56 PM | HOUGEN ELIZABETH LDirector | Grant/Award | 13,750 | $10.88 | 13,750(D) | View → |
| Sep 8, 2026 | Sep 8 9:56 PM | Brian DanielsDirector | Grant/Award | 13,750 | $10.88 | 13,750(D) | View → |
| Sep 8, 2026 | Sep 8 9:55 PM | Daniel G. BakerDirector | Grant/Award | 13,750 | $10.88 | 13,750(D) | View → |
| Sep 8, 2026 | Sep 8 9:55 PM | Alison MooreDirector | Grant/Award | 13,750 | $10.88 | 13,750(D) | View → |
Page 1 of 2
Next →